In-Silico Structure Database (LMISSD)
BackLMISSD: Lipid Classification search results
Fatty Acyls [FA](W) --> Docosanoids [FA04] --> Neuroprostanes [FA0401]
| LM_ID | Common Name | Systematic Name | Formula | Mass |
|---|---|---|---|---|
| LMFA04010103 | 14-F4c-NeuroP | (Z)-6-((1R,2S,3R,5S)-3,5-dihydroxy-2-((S,1E,5Z,8Z)-3-hydroxyundeca-1,5,8-trien-1-yl)cyclopentyl)hex-4-enoic acid | C22H34O5 | 378.2406 |
| LMFA04010105 | 7-epi-14-F4c-NeuroP | (Z)-6-((1S,2S,3R,5S)-3,5-dihydroxy-2-((S,1E,5Z,8Z)-3-hydroxyundeca-1,5,8-trien-1-yl)cyclopentyl)hex-4-enoic acid | C22H34O5 | 378.2406 |
| LMFA04010106 | 14-F4t-NeuroP | (Z)-6-((1S,2R,3R,5S)-3,5-dihydroxy-2-((S,1E,5Z,8Z)-3-hydroxyundeca-1,5,8-trien-1-yl)cyclopentyl)hex-4-enoic acid | C22H34O5 | 378.2406 |
| LMFA04010107 | ent-17-F4t-NeuroP | (4Z,7Z)-9-((1R,2S,3S,5R)-3,5-dihydroxy-2-((R,1E,5Z)-3-hydroxyocta-1,5-dien-1-yl)cyclopentyl)nona-4,7-dienoic acid | C22H34O5 | 378.2406 |
| LMFA04010108 | ent-10-epi-17-F4c-NeuroP | (4Z,7Z)-9-((1R,2R,3S,5R)-3,5-dihydroxy-2-((R,1E,5Z)-3-hydroxyocta-1,5-dien-1-yl)cyclopentyl)nona-4,7-dienoic acid | C22H34O5 | 378.2406 |
| LMFA04010109 | ent-10-epi-17-F4t-NeuroP | (4Z,7Z)-9-((1S,2S,3S,5R)-3,5-dihydroxy-2-((R,1E,5Z)-3-hydroxyocta-1,5-dien-1-yl)cyclopentyl)nona-4,7-dienoic acid | C22H34O5 | 378.2406 |
| LMFA04010110 | ent-17-F4c-NeuroP | (4Z,7Z)-9-((1S,2R,3S,5R)-3,5-dihydroxy-2-((R,1E,5Z)-3-hydroxyocta-1,5-dien-1-yl)cyclopentyl)nona-4,7-dienoic acid | C22H34O5 | 378.2406 |
| LMFA04010111 | ent-17-epi-17-F4t-NeuroP | (4Z,7Z)-9-((1R,2S,3S,5R)-3,5-dihydroxy-2-((S,1E,5Z)-3-hydroxyocta-1,5-dien-1-yl)cyclopentyl)nona-4,7-dienoic acid | C22H34O5 | 378.2406 |
| LMFA04010112 | ent-10,17-diepi-17-F4c-NeuroP | (4Z,7Z)-9-((1R,2R,3S,5R)-3,5-dihydroxy-2-((S,1E,5Z)-3-hydroxyocta-1,5-dien-1-yl)cyclopentyl)nona-4,7-dienoic acid | C22H34O5 | 378.2406 |
| LMFA04010113 | ent-10,17-diepi-17-F4t-NeuroP | (4Z,7Z)-9-((1S,2S,3S,5R)-3,5-dihydroxy-2-((S,1E,5Z)-3-hydroxyocta-1,5-dien-1-yl)cyclopentyl)nona-4,7-dienoic acid | C22H34O5 | 378.2406 |
| LMFA04010114 | ent-17-epi-17-F4t-NeuroP | (4Z,7Z)-9-((1S,2R,3S,5R)-3,5-dihydroxy-2-((S,1E,5Z)-3-hydroxyocta-1,5-dien-1-yl)cyclopentyl)nona-4,7-dienoic acid | C22H34O5 | 378.2406 |
| LMFA04010115 | 17-epi-17-F4c-NeuroP | (4Z,7Z)-9-((1R,2S,3R,5S)-3,5-dihydroxy-2-((R,1E,5Z)-3-hydroxyocta-1,5-dien-1-yl)cyclopentyl)nona-4,7-dienoic acid | C22H34O5 | 378.2406 |
| LMFA04010116 | 10,17-diepi-17-F4t-NeuroP | (4Z,7Z)-9-((1R,2R,3R,5S)-3,5-dihydroxy-2-((R,1E,5Z)-3-hydroxyocta-1,5-dien-1-yl)cyclopentyl)nona-4,7-dienoic acid | C22H34O5 | 378.2406 |
| LMFA04010117 | 10,17-diepi-17-F4c-NeuroP | (4Z,7Z)-9-((1S,2S,3R,5S)-3,5-dihydroxy-2-((R,1E,5Z)-3-hydroxyocta-1,5-dien-1-yl)cyclopentyl)nona-4,7-dienoic acid | C22H34O5 | 378.2406 |
| LMFA04010118 | 17-epi-17-F4t-NeuroP | (4Z,7Z)-9-((1S,2R,3R,5S)-3,5-dihydroxy-2-((R,1E,5Z)-3-hydroxyocta-1,5-dien-1-yl)cyclopentyl)nona-4,7-dienoic acid | C22H34O5 | 378.2406 |
| LMFA04010119 | 17-F4c-NeuroP | (4Z,7Z)-9-((1R,2S,3R,5S)-3,5-dihydroxy-2-((S,1E,5Z)-3-hydroxyocta-1,5-dien-1-yl)cyclopentyl)nona-4,7-dienoic acid | C22H34O5 | 378.2406 |
| LMFA04010120 | 10-epi-17-F4t-NeuroP | (4Z,7Z)-9-((1R,2R,3R,5S)-3,5-dihydroxy-2-((S,1E,5Z)-3-hydroxyocta-1,5-dien-1-yl)cyclopentyl)nona-4,7-dienoic acid | C22H34O5 | 378.2406 |
| LMFA04010121 | 10-epi-17-F4c-NeuroP | (4Z,7Z)-9-((1S,2S,3R,5S)-3,5-dihydroxy-2-((S,1E,5Z)-3-hydroxyocta-1,5-dien-1-yl)cyclopentyl)nona-4,7-dienoic acid | C22H34O5 | 378.2406 |
| LMFA04010122 | 17-F4t-NeuroP | (4Z,7Z)-9-((1S,2R,3R,5S)-3,5-dihydroxy-2-((S,1E,5Z)-3-hydroxyocta-1,5-dien-1-yl)cyclopentyl)nona-4,7-dienoic acid | C22H34O5 | 378.2406 |
| LMFA04010123 | ent-20-F4t-NeuroP | (4Z,7Z,10Z)-12-((1R,2S,3S,5R)-3,5-dihydroxy-2-((R,E)-3-hydroxypent-1-en-1-yl)cyclopentyl)dodeca-4,7,10-trienoic acid | C22H34O5 | 378.2406 |
| LMFA04010124 | ent-13-epi-20-F4c-NeuroP | (4Z,7Z,10Z)-12-((1R,2R,3S,5R)-3,5-dihydroxy-2-((R,E)-3-hydroxypent-1-en-1-yl)cyclopentyl)dodeca-4,7,10-trienoic acid | C22H34O5 | 378.2406 |
| LMFA04010125 | ent-13-epi-20-F4t-NeuroP | (4Z,7Z,10Z)-12-((1S,2S,3S,5R)-3,5-dihydroxy-2-((R,E)-3-hydroxypent-1-en-1-yl)cyclopentyl)dodeca-4,7,10-trienoic acid | C22H34O5 | 378.2406 |
| LMFA04010126 | ent-20-F4c-NeuroP | (4Z,7Z,10Z)-12-((1S,2R,3S,5R)-3,5-dihydroxy-2-((R,E)-3-hydroxypent-1-en-1-yl)cyclopentyl)dodeca-4,7,10-trienoic acid | C22H34O5 | 378.2406 |
| LMFA04010127 | ent-20-epi-20-F4t-NeuroP | (4Z,7Z,10Z)-12-((1R,2S,3S,5R)-3,5-dihydroxy-2-((S,E)-3-hydroxypent-1-en-1-yl)cyclopentyl)dodeca-4,7,10-trienoic acid | C22H34O5 | 378.2406 |
| LMFA04010128 | ent-13,20-diepi-20-F4c-NeuroP | (4Z,7Z,10Z)-12-((1R,2R,3S,5R)-3,5-dihydroxy-2-((S,E)-3-hydroxypent-1-en-1-yl)cyclopentyl)dodeca-4,7,10-trienoic acid | C22H34O5 | 378.2406 |
| LMFA04010129 | ent-13,20-diepi-20-F4t-NeuroP | (4Z,7Z,10Z)-12-((1S,2S,3S,5R)-3,5-dihydroxy-2-((S,E)-3-hydroxypent-1-en-1-yl)cyclopentyl)dodeca-4,7,10-trienoic acid | C22H34O5 | 378.2406 |
| LMFA04010130 | ent-20-epi-20-F4t-NeuroP | (4Z,7Z,10Z)-12-((1S,2R,3S,5R)-3,5-dihydroxy-2-((S,E)-3-hydroxypent-1-en-1-yl)cyclopentyl)dodeca-4,7,10-trienoic acid | C22H34O5 | 378.2406 |
| LMFA04010131 | 20-epi-20-F4c-NeuroP | (4Z,7Z,10Z)-12-((1R,2S,3R,5S)-3,5-dihydroxy-2-((R,E)-3-hydroxypent-1-en-1-yl)cyclopentyl)dodeca-4,7,10-trienoic acid | C22H34O5 | 378.2406 |
| LMFA04010132 | 13,20-diepi-20-F4t-NeuroP | (4Z,7Z,10Z)-12-((1R,2R,3R,5S)-3,5-dihydroxy-2-((R,E)-3-hydroxypent-1-en-1-yl)cyclopentyl)dodeca-4,7,10-trienoic acid | C22H34O5 | 378.2406 |
| LMFA04010133 | 13,20-diepi-20-F4c-NeuroP | (4Z,7Z,10Z)-12-((1S,2S,3R,5S)-3,5-dihydroxy-2-((R,E)-3-hydroxypent-1-en-1-yl)cyclopentyl)dodeca-4,7,10-trienoic acid | C22H34O5 | 378.2406 |
| LMFA04010134 | 20-epi-20-F4t-NeuroP | (4Z,7Z,10Z)-12-((1S,2R,3R,5S)-3,5-dihydroxy-2-((R,E)-3-hydroxypent-1-en-1-yl)cyclopentyl)dodeca-4,7,10-trienoic acid | C22H34O5 | 378.2406 |
| LMFA04010135 | 20-F4c-NeuroP | (4Z,7Z,10Z)-12-((1R,2S,3R,5S)-3,5-dihydroxy-2-((S,E)-3-hydroxypent-1-en-1-yl)cyclopentyl)dodeca-4,7,10-trienoic acid | C22H34O5 | 378.2406 |
| LMFA04010136 | 13-epi-20-F4t-NeuroP | (4Z,7Z,10Z)-12-((1R,2R,3R,5S)-3,5-dihydroxy-2-((S,E)-3-hydroxypent-1-en-1-yl)cyclopentyl)dodeca-4,7,10-trienoic acid | C22H34O5 | 378.2406 |
| LMFA04010137 | 13-epi-20-F4c-NeuroP | (4Z,7Z,10Z)-12-((1S,2S,3R,5S)-3,5-dihydroxy-2-((S,E)-3-hydroxypent-1-en-1-yl)cyclopentyl)dodeca-4,7,10-trienoic acid | C22H34O5 | 378.2406 |
| LMFA04010138 | 20-F4t-NeuroP | (4Z,7Z,10Z)-12-((1S,2R,3R,5S)-3,5-dihydroxy-2-((S,E)-3-hydroxypent-1-en-1-yl)cyclopentyl)dodeca-4,7,10-trienoic acid | C22H34O5 | 378.2406 |
| LMFA04010139 | ent-4-D4t-NeuroP | (R,E)-4-hydroxy-6-((1R,2S,5R)-5-hydroxy-3-oxo-2-((2Z,5Z,8Z)-undeca-2,5,8-trien-1-yl)cyclopentyl)hex-5-enoic acid | C22H32O5 | 376.2250 |
| LMFA04010140 | ent-7-epi-4-D4c-NeuroP | (R,E)-4-hydroxy-6-((1R,2R,5R)-5-hydroxy-3-oxo-2-((2Z,5Z,8Z)-undeca-2,5,8-trien-1-yl)cyclopentyl)hex-5-enoic acid | C22H32O5 | 376.2250 |
| LMFA04010141 | ent-7-epi-4-D4t-NeuroP | (R,E)-4-hydroxy-6-((1S,2S,5R)-5-hydroxy-3-oxo-2-((2Z,5Z,8Z)-undeca-2,5,8-trien-1-yl)cyclopentyl)hex-5-enoic acid | C22H32O5 | 376.2250 |
| LMFA04010142 | ent-4-D4c-NeuroP | (R,E)-4-hydroxy-6-((1S,2R,5R)-5-hydroxy-3-oxo-2-((2Z,5Z,8Z)-undeca-2,5,8-trien-1-yl)cyclopentyl)hex-5-enoic acid | C22H32O5 | 376.2250 |
| LMFA04010143 | 4-epi-4-D4c-NeuroP | (R,E)-4-hydroxy-6-((1R,2S,5S)-5-hydroxy-3-oxo-2-((2Z,5Z,8Z)-undeca-2,5,8-trien-1-yl)cyclopentyl)hex-5-enoic acid | C22H32O5 | 376.2250 |
| LMFA04010144 | 4,7-diepi-4-D4t-NeuroP | (R,E)-4-hydroxy-6-((1R,2R,5S)-5-hydroxy-3-oxo-2-((2Z,5Z,8Z)-undeca-2,5,8-trien-1-yl)cyclopentyl)hex-5-enoic acid | C22H32O5 | 376.2250 |
| LMFA04010145 | 4,7-diepi-4-D4c-NeuroP | (R,E)-4-hydroxy-6-((1S,2S,5S)-5-hydroxy-3-oxo-2-((2Z,5Z,8Z)-undeca-2,5,8-trien-1-yl)cyclopentyl)hex-5-enoic acid | C22H32O5 | 376.2250 |
| LMFA04010146 | 4-epi-4-D4t-NeuroP | (R,E)-4-hydroxy-6-((1S,2R,5S)-5-hydroxy-3-oxo-2-((2Z,5Z,8Z)-undeca-2,5,8-trien-1-yl)cyclopentyl)hex-5-enoic acid | C22H32O5 | 376.2250 |
| LMFA04010147 | ent-4-epi-4-D4t-NeuroP | (S,E)-4-hydroxy-6-((1R,2S,5R)-5-hydroxy-3-oxo-2-((2Z,5Z,8Z)-undeca-2,5,8-trien-1-yl)cyclopentyl)hex-5-enoic acid | C22H32O5 | 376.2250 |
| LMFA04010148 | ent-4,7-diepi-4-D4c-NeuroP | (S,E)-4-hydroxy-6-((1R,2R,5R)-5-hydroxy-3-oxo-2-((2Z,5Z,8Z)-undeca-2,5,8-trien-1-yl)cyclopentyl)hex-5-enoic acid | C22H32O5 | 376.2250 |
| LMFA04010149 | ent-4,7-diepi-4-D4t-NeuroP | (S,E)-4-hydroxy-6-((1S,2S,5R)-5-hydroxy-3-oxo-2-((2Z,5Z,8Z)-undeca-2,5,8-trien-1-yl)cyclopentyl)hex-5-enoic acid | C22H32O5 | 376.2250 |
| LMFA04010150 | ent-4-epi-4-D4c-NeuroP | (S,E)-4-hydroxy-6-((1S,2R,5R)-5-hydroxy-3-oxo-2-((2Z,5Z,8Z)-undeca-2,5,8-trien-1-yl)cyclopentyl)hex-5-enoic acid | C22H32O5 | 376.2250 |
| LMFA04010151 | 4-D4c-NeuroP | (S,E)-4-hydroxy-6-((1R,2S,5S)-5-hydroxy-3-oxo-2-((2Z,5Z,8Z)-undeca-2,5,8-trien-1-yl)cyclopentyl)hex-5-enoic acid | C22H32O5 | 376.2250 |
| LMFA04010152 | 7-epi-4-D4t-NeuroP | (S,E)-4-hydroxy-6-((1R,2R,5S)-5-hydroxy-3-oxo-2-((2Z,5Z,8Z)-undeca-2,5,8-trien-1-yl)cyclopentyl)hex-5-enoic acid | C22H32O5 | 376.2250 |
| LMFA04010153 | 7-epi-4-D4c-NeuroP | (S,E)-4-hydroxy-6-((1S,2S,5S)-5-hydroxy-3-oxo-2-((2Z,5Z,8Z)-undeca-2,5,8-trien-1-yl)cyclopentyl)hex-5-enoic acid | C22H32O5 | 376.2250 |